πŸŽ‰ Orders $200+ Get Free Domestic Shipping!

Retatrutide

RetatrutideΒ is a GGG tri-agonist that targets GLP-1 and GIP receptors, akin to standard GLP-1 agonists, but also uniquely activates the glucagon receptor. This extra receptor interaction enhances glucagon production, leading to the breakdown of stored fats and glycogen, thereby increasing basal metabolism for more consistent fat loss. Its actions on GLP-1 and GIP receptors promote delayed gastric emptying and appetite control, offering a comprehensive approach to obesity research distinct from older GLP-1 agonists. Further research is required.

$230.00

Quantity

🧬 Retatrutide – Triple Hormone Receptor Agonist for Metabolic Research

πŸ” Overview

Retatrutide (LY3437943) is a synthetic peptide designed as a triple agonist for the GLP-1, GIP, and glucagon receptors. This unique mechanism positions Retatrutide as a valuable compound in metabolic research, particularly in studies related to obesity, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD).

⚠️ For Research Use Only – Not for human consumption or therapeutic applications.

βš™οΈ Mechanism of Action

Retatrutide simultaneously activates three key receptors involved in metabolic regulation:

  • 🧬 GLP-1 Receptor (Glucagon-Like Peptide-1): Enhances insulin secretion, suppresses glucagon release, and slows gastric emptying.

 

  • πŸ§ͺ GIP Receptor (Glucose-Dependent Insulinotropic Polypeptide): Stimulates insulin release and may improve insulin sensitivity.

 

  • πŸ”₯ Glucagon Receptor: Increases energy expenditure and may aid in weight management.

This triagonist approach offers a synergistic effect, potentially leading to superior outcomes in metabolic research compared to single or dual agonist compounds.

πŸ“Š Research Highlights

  • Weight Reduction: Studies report up to 24% weight loss over 48 weeks in research participants.

 

  • Glycemic Control: Notable improvements in HbA1c and glucose tolerance markers.

 

  • Liver Health: Reduced liver fat content in early studies targeting NAFLD.

πŸ§ͺ Additional Research Areas

  • πŸ«€ Cardiovascular health and lipid profile support

 

  • 🧬 Anti-inflammatory activity across metabolic tissues

 

  • ⚑ Enhanced basal metabolic rate and energy expenditure

βœ… Safety & Observations

Retatrutide has been generally well-tolerated in preclinical and early human studies. Mild GI symptoms such as nausea and diarrhea have been observed, typically decreasing over time.

Note: Research use only. Not approved for human or veterinary applications.

🧾 Peptide Details & Structure

  • Amino Acid Sequence: Tyr-Aib-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-MeLeu-Leu-Asp-Lys-Lys(AEEA-Ξ³-Glu-C20 diacid)-Ala-Gln-Aib-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NHβ‚‚

 

  • Molecular Formula: C₂₂₁H₃₄₂N₄₆Oβ‚†β‚ˆ

 

  • Molecular Weight: 4731.33 g/mol

 

  • CAS Number: 2381089-83-2

 

  • Synonyms: LY3437943

🧬 Molecular Structure Illustration

πŸ“š References

 

 

 

 

A free Bacteriostatic water is included in every order.

Subscribe to our newsletter

Want to get 15% OFF site-wide plus a FREE keychain? Subscribe to our newsletter to claim this offer!

Please wait...

Thank you for subscribing!